ArticleMethods and protocols2025
A Study Protocol on Risk Prediction Modelling of Mortality and In-Hospital Major Bleeding Following Percutaneous Coronary Intervention in an Australian Population: Machine Learning Approach.
Article in Methods and protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Development and validation of an interpretable machine learning model for predicting 5-year recurrence in breast cancer.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Machine learning (ML) excels over regression by automatically capturing complex, non-linear relationships and interactions, enabling more flexible and accurate predictions without strict assumptions. This study focuses on developing ML-based predictive models for key post-PCI outcomes: 30-day mortality, in-hospital major bleeding, and one-year mortality. Data from 104,665 consecutive PCI cases in the Victorian Cardiac Outcomes Registry (VCOR), collected between 2013 and 2022, will be analyzed. Candidate variables, informed by prior systematic reviews and dataset availability, will undergo multiple imputations for missing values. The Boruta method will be applied to identify influential predictors. Risk-adjusted models will be developed using sophisticated ML algorithms, with performance compared across standard metrics for validation. The dataset will be split, optimized via 10-fold cross-validation, and class imbalance addressed using Adaptive Synthetic resampling technique. SHapley Additive exPlanations will interpret the most influential predictors. The variables from the best model will be converted into simplified numeric scores. External validation will be performed using the Tasmanian dataset or equivalent datasets. This study is expected to identify the most influential variables associated with 30-day all-cause mortality, in-hospital major bleeding, and long-term mortality post-PCI. These variables will form the basis for developing robust risk-scoring models to support clinical decision-making and outcome prediction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.